Unorthodox Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Sonavex develops medical device technologies focused on vascular access and related clinical applications, drawing on ultrasound-based imaging and monitoring products.
BiotechDigital HealthHealthtechMedical DevicesBaltimore, US
David Narrow(Executive Officer, Director)Devin O'Brien-Coon(Co-Founder & Chairman)Jerry L. Prince(Co-Founder)John Rappe(Executive Officer)Jerry Prince(Director)Alex Yevzlin(Executive Officer)
Co-investorsFusionJStar Capital InvestmentsKeiretsu ForumMaryland TEDCORembrandt Venture PartnersRiptide Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.